Connect your AI

MaxCyte MXCT Business Segments — Research And Development Expense

Similar metrics at other companies

AMPGManufacturing And Engineering — Research And Development Expense

$503.05K-32.0%

HXLEngineered Products — Research And Development Expense

$1.5M+36.4%

FLGTTherapeutic Development — Research And Development Expense

$4.18M+4.7%

STIMMedical Device — Research And Development Expense

$1.31M-16.6%

KULREnergy Management Platform — Research And Development Expense

$1.77M-27.7%

MBLYMobileye — Research And Development Expense

$245M+15.6%

Other financials

Income statement

Revenue$9.7M-7.1%

Gross profit$8.1M-9.1%

Operating income-$6.2M+49.7%

Net income-$4.8M+53.7%

EPS (diluted)-$0.04+60.0%

Balance sheet

Cash & equivalents$14.6M-37.8%

Total debt$17.5M-7.1%

Total equity$167.9M-15.8%

Total assets$194.5M-15.4%

Cash flow

Operating cash flow-$8.2M+43.3%

CapEx$72.0K-89.0%

Free cash flow-$8.2M+45.3%

Valuation

Market cap$130.15M-46.8%

Enterprise value$133.08M-46.3%

P/S4×-2.8×

Profitability

Gross margin80.5%-0.4pp

Operating margin-141.8%+6.4pp

Net margin-121.2%+12.3pp

FCF margin-90.9%+3.7pp

Returns & leverage

Return on equity-21.3%+2.0pp

Debt / equity0.1×0.0×

Current ratio12×-0.2×

Where this comes from

Reported directly by MaxCyte in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's business segments — research and development expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is MaxCyte's business segments — research and development expense?: MaxCyte (MXCT) reported business segments — research and development expense of $3.71M in Q1 2026.
How has MaxCyte's business segments — research and development expense changed year-over-year?: MaxCyte's business segments — research and development expense decreased by 29.6% year-over-year, from $5.27M to $3.71M.
What does business segments — research and development expense mean?: Reflects the costs incurred for research and development activities aimed at advancing the company's proprietary cell engineering platforms and supporting next-generation therapeutic discovery. This investment is critical for maintaining long-term competitive advantage and technological innovation.